tiprankstipranks
Summit Therapeutics PLC (SMMT)
NASDAQ:SMMT
US Market

Compare Summit Therapeutics (SMMT) vs. Competitors

1,872 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Summit Therapeutics
$19.67
$15.25B
-2.38%
10 Buy
2 Hold
0 Sell
Strong Buy
Incyte
$96.07
$19.12B
14.98
74.13%
7 Buy
9 Hold
1 Sell
Moderate Buy
United Therapeutics
$571.73
$25.06B
16.17
105.00%
10 Buy
4 Hold
0 Sell
Moderate Buy
Ascendis Pharma
$239.28
$14.69B
-50.22
66.94%
13 Buy
0 Hold
0 Sell
Strong Buy
Genmab
$28.25
$17.25B
19.86
56.86%
8 Buy
2 Hold
0 Sell
Strong Buy
BioNTech SE
$95.50
$24.00B
-17.95
2.56%
14 Buy
2 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
SMMT
Summit Therapeutics
19.67
-6.46
-24.72%
INCY
Incyte
96.07
36.85
62.23%
UTHR
United Therapeutics
571.73
287.42
101.09%
ASND
Ascendis Pharma
239.28
83.78
53.88%
GMAB
Genmab
28.25
8.93
46.22%
BNTX
BioNTech SE
95.50
-6.84
-6.68%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts